Skip to main content

Table 1 The multivariate analyses of factors associated with overall survival and cancer-specific survival

From: Conditional survival after surgical resection of primary retroperitoneal tumors: a population-based study

Variable

OS-multivariate Cox regression

CSS-multivariate Cox regression

HR (95% CI)

P-value

HR (95% CI)

P-value

Age

 < 65

    

 ≥ 65

1.915 (1.636–2.241)

 < 0.001

1.698 (1.417–2.035)

 < 0.001

Sex

Male

    

Female

0.778 (0.663–0.913)

0.002

0.814 (0.680–0.975)

0.025

Race

White

    

Black

    

API

    

Other

    

Marital status

    

Married

    

Unmarried

1.078 (0.863–1.347)

0.510

  

Unknown

1.282 (1.069–1.538)

0.007

  

FNCLCC grade

I

    

II

1.846 (1.130–3.016)

0.014

1.942 (1.060–3.560)

0.032

III

3.119 (2.075–4.688)

 < 0.001

3.569 (2.128–5.985)

 < 0.001

Unknown

1.986 (1.359–2.902)

 < 0.001

2.263 (1.385–3.697)

0.001

Size (cm)

 < 5

    

5–10

1.105 (0.719–1.697)

0.650

1.048 (0.635–1.730)

0.855

10–15

1.397 (0.905–2.155)

0.131

1.377 (0.830–2.285)

0.215

 ≥ 15

1.832 (1.220–2.752)

0.004

1.843 (1.147–2.961)

0.011

Unknown

2.623 (1.567–4.393)

 < 0.001

2.366 (1.282–4.367)

0.006

Multifocality

No

    

Yes

0.588 (0.464–0.746)

 < 0.001

0.111 (0.063–0.198)

 < 0.001

Histology

SFT

    

MFHC

2.942 (1.280–6.763)

0.011

2.626 (1.061–6.497)

0.037

MPNST

1.914 (0.635–5.775)

0.249

0.727 (0.145–3.639)

0.698

LMS

1.578 (0.734–3.392)

0.242

1.496 (0.655–3.419)

0.339

DD lipo

1.404 (0.657–2.999)

0.382

1.276 (0.562–2.900)

0.560

WD lipo

0.679 (0.311–1.482)

0.331

0.435 (0.183–1.034)

0.060

Other

1.361 (0.638–2.901)

0.425

1.242 (0.548–2.813)

0.603

Radiation

No

    

Yes

    

Chemotherapy

No

    

Yes

1.606 (1.320–1.953)

 < 0.001

1.810 (1.464–2.238)

 < 0.001

Chemoradiotherapy

No

    

Yes

    

Extent of resection

Complete

    

Incomplete

    

Unknown

    
  1. SFT solitary fibrous tumor, MFHC Malignant fibrous histiocytoma, MPNST malignant peripheral nerve sheath tumor, LMS leiomyosarcoma, DD lipo dedifferentiated liposarcoma, WD lipo well-differentiated liposarcoma, FNCLCC French National Federation of the Centers for the Fight Against Cancer, API Asian/Pacific Islander, OS overall survival, CSS cancer-specific survival